speb/financial-data huggingface dataset:
DME.AX balance_sheet (annual, 2021-06-30) — Total Capitalization: 32763151.00
DME.AX balance_sheet (annual, 2021-06-30) — Total Debt: 899454.00
DME.AX balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 31863697.00
DME.AX balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 1189990.00
DME.AX balance_sheet (annual, 2021-06-30) — Total Non Current Assets: 32752936.00
DME.AX balance_sheet (annual, 2021-06-30) — Total Non Current Liabilities Net Minority Interest: 899454.00
DME.AX income_statement (annual, 2021-06-30) — Total Other Finance Cost: 3757.00
DME.AX income_statement (annual, 2021-06-30) — Total Unusual Items: -8874.00
DME.AX income_statement (annual, 2021-06-30) — Total Unusual Items Excluding Goodwill: -8874.00
DME.AX balance_sheet (annual, 2021-06-30) — Working Capital: 10215.00
DME.AX income_statement (annual, 2022-06-30) — +Operating Expense: 1984276.00
DME.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 115120.00
DME.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -556338.00
DME.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 329706352.00
DME.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.01
DME.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 200568.00
DME.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -941007.00
DME.AX cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -880837.00
DME.AX balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 22662.00
DME.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 48809155.00
DME.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 4131270.00
DME.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 4138770.00
DME.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 4131270.00
DME.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 6715442.00
DME.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -942036.00
DME.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1843266.00
DME.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 3930140.00
DME.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -1836565.00
DME.AX balance_sheet (annual, 2022-06-30) — Common Stock: 48809155.00
DME.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 37911257.00
DME.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 7620217.00
DME.AX balance_sheet (annual, 2022-06-30) — Current Assets: 4237604.00
DME.AX balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 22662.00
DME.AX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 22662.00
DME.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 439927.00
DME.AX balance_sheet (annual, 2022-06-30) — Current Provisions: 12938.00
DME.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 6651.00
DME.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 6651.00
DME.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 6651.00
DME.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 329706352.00
DME.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.01
DME.AX income_statement (annual, 2022-06-30) — EBIT: -1977463.00
DME.AX income_statement (annual, 2022-06-30) — EBITDA: -1970812.00
DME.AX cash_flow (annual, 2022-06-30) — Effect Of Exchange Rate Changes: 562.00
DME.AX cash_flow (annual, 2022-06-30) — End Cash Position: 4131270.00
DME.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 6715442.00
DME.AX balance_sheet (annual, 2022-06-30) — Foreign Currency Translation Adjustments: 241957.00
DME.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -2784273.00
DME.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 7740619.00
DME.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 714594.00
DME.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 34569182.00
DME.AX cash_flow (annual, 2022-06-30) — Income Tax Paid Supplemental Data: -3591.00
DME.AX income_statement (annual, 2022-06-30) — Interest Expense: 11930.00
DME.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 11930.00
DME.AX income_statement (annual, 2022-06-30) — Interest Income: 1710.00
DME.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 1710.00
DME.AX cash_flow (annual, 2022-06-30) — Interest Paid Direct: -11930.00
DME.AX cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 11930.00
DME.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 1638.00
DME.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 37911257.00
DME.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -942036.00
DME.AX balance_sheet (annual, 2022-06-30) — Investments And Advances: 97698.00
DME.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 7620217.00
DME.AX cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -899453.00
DME.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 608160.00
DME.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 7620217.00
DME.AX income_statement (annual, 2022-06-30) — Net Income: -1989393.00
DME.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -1989393.00
DME.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -1989393.00
DME.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -1989393.00
DME.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -1989393.00
DME.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -1989393.00
DME.AX income_statement (annual, 2022-06-30) — Net Interest Income: -10220.00
DME.AX cash_flow (annual, 2022-06-30) — Net Investment Purchase And Sale: -1029.00
DME.AX cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -899453.00
DME.AX cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -899453.00
DME.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -10220.00
DME.AX cash_flow (annual, 2022-06-30) — Net Other Financing Charges: -5322.00
DME.AX balance_sheet (annual, 2022-06-30) — Net PPE: 34012844.00
DME.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -60170.00
DME.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 37911257.00
DME.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -1970812.00
DME.AX income_statement (annual, 2022-06-30) — Normalized Income: -1989393.00
DME.AX income_statement (annual, 2022-06-30) — Operating Income: -1984276.00
DME.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 350104136.00
DME.AX balance_sheet (annual, 2022-06-30) — Other Current Assets: 7500.00
DME.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 7498662.00
DME.AX income_statement (annual, 2022-06-30) — Other Income Expense: 5103.00
DME.AX balance_sheet (annual, 2022-06-30) — Other Investments: 97698.00
DME.AX balance_sheet (annual, 2022-06-30) — Other Non Current Assets: 3038.00
DME.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 5103.00
DME.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 1263031.00
DME.AX balance_sheet (annual, 2022-06-30) — Other Payable: 289207.00
DME.AX balance_sheet (annual, 2022-06-30) — Other Properties: 33961022.00
DME.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 48851.00
DME.AX balance_sheet (annual, 2022-06-30) — Other Short Term Investments: 7500.00
DME.AX balance_sheet (annual, 2022-06-30) — Payables: 404327.00
DME.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 404327.00
DME.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -1836565.00
DME.AX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 49983.00
DME.AX income_statement (annual, 2022-06-30) — Pretax Income: -1989393.00
DME.AX cash_flow (annual, 2022-06-30) — Purchase Of Investment: -1029.00
DME.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -60170.00
DME.AX balance_sheet (annual, 2022-06-30) — Receivables: 48851.00
DME.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 6651.00
DME.AX income_statement (annual, 2022-06-30) — Rent And Landing Fees: 92400.00
DME.AX cash_flow (annual, 2022-06-30) — Repayment Of Debt: -899453.00
DME.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -18638517.00
DME.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 622194.00
DME.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 714594.00
DME.AX balance_sheet (annual, 2022-06-30) — Share Issued: 350104136.00
DME.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 37911257.00
DME.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 37911257.00
DME.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
DME.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
DME.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
DME.AX cash_flow (annual, 2022-06-30) — Taxes Refund Paid Direct: 3591.00
DME.AX balance_sheet (annual, 2022-06-30) — Total Assets: 38351184.00
DME.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 37911257.00
DME.AX balance_sheet (annual, 2022-06-30) — Total Debt: 22662.00
DME.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 37911257.00
DME.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 439927.00
DME.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 34113580.00
DME.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
DME.AX balance_sheet (annual, 2022-06-30) — Working Capital: 3797677.00
DME.AX income_statement (annual, 2023-06-30) — +Operating Expense: 2997882.00
DME.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 118930.00
DME.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -594647.00
DME.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 351781999.00
DME.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.01
DME.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 4131270.00
DME.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -2567332.00
DME.AX cash_flow (annual, 2023-06-30) — Capital Expenditure Reported: -2549955.00
DME.AX balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 40649.00
DME.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 49149196.00
DME.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 100465.00
DME.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 107965.00
DME.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 100465.00
DME.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 680398.00
DME.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -2710457.00
DME.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -2001460.00
DME.AX cash_flow (annual, 2023-06-30) — Changes In Cash: -4031519.00
DME.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -2016688.00
DME.AX balance_sheet (annual, 2023-06-30) — Common Stock: 49149196.00
DME.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 35535973.00
DME.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 405380.00
DME.AX balance_sheet (annual, 2023-06-30) — Current Assets: 205741.00
DME.AX balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 16272.00
DME.AX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 16272.00
DME.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 264088.00
DME.AX balance_sheet (annual, 2023-06-30) — Current Provisions: 11223.00
DME.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 5981.00
DME.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 5981.00
DME.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 5981.00
DME.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 351781999.00
DME.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.01
DME.AX income_statement (annual, 2023-06-30) — EBIT: -2989649.00
DME.AX income_statement (annual, 2023-06-30) — EBITDA: -2983668.00
DME.AX cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: 714.00
DME.AX cash_flow (annual, 2023-06-30) — End Cash Position: 100465.00
DME.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 680398.00
DME.AX balance_sheet (annual, 2023-06-30) — Foreign Currency Translation Adjustments: 460723.00
DME.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -4568792.00
DME.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 7929860.00
DME.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 570065.00
DME.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 36253712.00
DME.AX cash_flow (annual, 2023-06-30) — Income Tax Paid Supplemental Data: -6207.00
DME.AX income_statement (annual, 2023-06-30) — Interest Expense: 1566.00
DME.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 1566.00
DME.AX income_statement (annual, 2023-06-30) — Interest Income: 9064.00
DME.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 9064.00
DME.AX cash_flow (annual, 2023-06-30) — Interest Paid Direct: -43.00
DME.AX cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 43.00
DME.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 9064.00
DME.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 35822496.00
DME.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -2710457.00
DME.AX balance_sheet (annual, 2023-06-30) — Investments And Advances: 243023.00
DME.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 405380.00
DME.AX cash_flow (annual, 2023-06-30) — Issuance Of Debt: 285000.00
DME.AX balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 24377.00
DME.AX balance_sheet (annual, 2023-06-30) — Long Term Debt: 286523.00
DME.AX balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 310900.00
DME.AX cash_flow (annual, 2023-06-30) — Long Term Debt Issuance: 285000.00
DME.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 632990.00
DME.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 405380.00
DME.AX balance_sheet (annual, 2023-06-30) — Net Debt: 186058.00
DME.AX income_statement (annual, 2023-06-30) — Net Income: -2991215.00
DME.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -2991215.00
DME.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -2991215.00
DME.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -2991215.00
DME.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -2991215.00
DME.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -2991215.00
DME.AX income_statement (annual, 2023-06-30) — Net Interest Income: 7498.00
DME.AX cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: -143125.00
DME.AX cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: 285000.00
DME.AX cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: 285000.00
DME.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: 7498.00
DME.AX cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -9982.00
DME.AX balance_sheet (annual, 2023-06-30) — Net PPE: 35659065.00
DME.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -17377.00
DME.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 35535973.00
DME.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -2983668.00
DME.AX income_statement (annual, 2023-06-30) — Normalized Income: -2991215.00
DME.AX income_statement (annual, 2023-06-30) — Operating Income: -2997882.00
DME.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 353214136.00
DME.AX balance_sheet (annual, 2023-06-30) — Other Current Assets: 7500.00
DME.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 7469137.00
DME.AX income_statement (annual, 2023-06-30) — Other Income Expense: -831.00
DME.AX balance_sheet (annual, 2023-06-30) — Other Investments: 243023.00
DME.AX balance_sheet (annual, 2023-06-30) — Other Non Current Assets: 3132.00
DME.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: -831.00
DME.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 2421836.00
DME.AX balance_sheet (annual, 2023-06-30) — Other Payable: 117663.00
DME.AX balance_sheet (annual, 2023-06-30) — Other Properties: 35620722.00
DME.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 49597.00
DME.AX balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 7500.00
DME.AX balance_sheet (annual, 2023-06-30) — Payables: 236593.00
DME.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 236593.00
DME.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -2016688.00
DME.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 48179.00
DME.AX income_statement (annual, 2023-06-30) — Pretax Income: -2991215.00
DME.AX cash_flow (annual, 2023-06-30) — Purchase Of Investment: -143125.00
DME.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -17377.00
DME.AX balance_sheet (annual, 2023-06-30) — Receivables: 49597.00
DME.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 5981.00
DME.AX income_statement (annual, 2023-06-30) — Rent And Landing Fees: 96096.00
DME.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -21543083.00
DME.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 473969.00
DME.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 570065.00
DME.AX balance_sheet (annual, 2023-06-30) — Share Issued: 353214136.00
DME.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 35535973.00
DME.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 35535973.00
DME.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
DME.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
DME.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
DME.AX cash_flow (annual, 2023-06-30) — Taxes Refund Paid Direct: 6207.00
DME.AX balance_sheet (annual, 2023-06-30) — Total Assets: 36110961.00
DME.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 35822496.00
DME.AX balance_sheet (annual, 2023-06-30) — Total Debt: 327172.00
DME.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 35535973.00
DME.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 574988.00
DME.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 35905220.00
DME.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 310900.00
DME.AX balance_sheet (annual, 2023-06-30) — Working Capital: -58347.00
DME.AX income_statement (annual, 2024-06-30) — +Operating Expense: 2106613.00
DME.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 372325.00
DME.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -645711.00
DME.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 358749400.00
DME.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.01
DME.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 100465.00
DME.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -419446.00
DME.AX cash_flow (annual, 2024-06-30) — Capital Expenditure Reported: -418156.00
DME.AX balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 51298.00
DME.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 50659480.00
DME.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 996.00
DME.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 8496.00
DME.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 996.00
DME.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 2110719.00
DME.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -419446.00
DME.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1790754.00
DME.AX cash_flow (annual, 2024-06-30) — Changes In Cash: -99481.00
DME.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -1764453.00
DME.AX balance_sheet (annual, 2024-06-30) — Common Stock: 50659480.00
DME.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 34920429.00
DME.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 1499055.00
DME.AX cash_flow (annual, 2024-06-30) — Common Stock Payments: -61383.00
DME.AX balance_sheet (annual, 2024-06-30) — Current Assets: 153499.00
DME.AX balance_sheet (annual, 2024-06-30) — Current Capital Lease Obligation: 44938.00
DME.AX balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 44938.00
DME.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 735005.00
DME.AX balance_sheet (annual, 2024-06-30) — Current Provisions: 22671.00
DME.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 4388.00
DME.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 4388.00
DME.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 4388.00
DME.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 358749400.00
DME.AX income_statement (annual, 2024-06-30) — Diluted EPS: -0.01
DME.AX income_statement (annual, 2024-06-30) — EBIT: -2105498.00
DME.AX income_statement (annual, 2024-06-30) — EBITDA: -2101110.00
DME.AX cash_flow (annual, 2024-06-30) — Effect Of Exchange Rate Changes: 12.00
DME.AX cash_flow (annual, 2024-06-30) — End Cash Position: 996.00
DME.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 2110719.00
DME.AX balance_sheet (annual, 2024-06-30) — Foreign Currency Translation Adjustments: 397487.00
DME.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -2210200.00
DME.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 6668387.00
DME.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 635778.00
DME.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 36786441.00
DME.AX cash_flow (annual, 2024-06-30) — Income Tax Paid Supplemental Data: 27527.00
DME.AX income_statement (annual, 2024-06-30) — Interest Expense: 71278.00
DME.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 71278.00
DME.AX income_statement (annual, 2024-06-30) — Interest Income: 1131.00
DME.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 1131.00
DME.AX cash_flow (annual, 2024-06-30) — Interest Paid Direct: -8.00
DME.AX cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: 8.00
DME.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 1234.00
DME.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 35789823.00
DME.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -419446.00
DME.AX balance_sheet (annual, 2024-06-30) — Investments And Advances: 241347.00
DME.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 1499055.00
DME.AX cash_flow (annual, 2024-06-30) — Issuance Of Debt: 977453.00
DME.AX balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 6360.00
DME.AX balance_sheet (annual, 2024-06-30) — Long Term Debt: 869394.00
DME.AX balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 875754.00
DME.AX cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 977453.00
DME.AX cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -266088.00
DME.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 617863.00
DME.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 1437672.00
DME.AX balance_sheet (annual, 2024-06-30) — Net Debt: 868398.00
DME.AX income_statement (annual, 2024-06-30) — Net Income: -2188585.00
DME.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -2188585.00
DME.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -2188585.00
DME.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -2188585.00
DME.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -2188585.00
DME.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -2188585.00
DME.AX income_statement (annual, 2024-06-30) — Net Interest Income: -70147.00
DME.AX cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: 711365.00
DME.AX cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: 711365.00
DME.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: -70147.00
DME.AX cash_flow (annual, 2024-06-30) — Net Other Financing Charges: -76636.00
DME.AX balance_sheet (annual, 2024-06-30) — Net PPE: 36140730.00
DME.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -1290.00
DME.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 34920429.00
DME.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -2101110.00
DME.AX income_statement (annual, 2024-06-30) — Normalized Income: -2188585.00
DME.AX income_statement (annual, 2024-06-30) — Operating Income: -2106613.00
DME.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 367739086.00
DME.AX balance_sheet (annual, 2024-06-30) — Other Current Assets: 7500.00
DME.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 6270900.00
DME.AX income_statement (annual, 2024-06-30) — Other Income Expense: -16.00
DME.AX balance_sheet (annual, 2024-06-30) — Other Investments: 241347.00
DME.AX balance_sheet (annual, 2024-06-30) — Other Non Current Assets: 244459.00
DME.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: -16.00
DME.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 1466447.00
DME.AX balance_sheet (annual, 2024-06-30) — Other Payable: 295071.00
DME.AX balance_sheet (annual, 2024-06-30) — Other Properties: 36168578.00
DME.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 88720.00
DME.AX balance_sheet (annual, 2024-06-30) — Other Short Term Investments: 7500.00
DME.AX balance_sheet (annual, 2024-06-30) — Payables: 667396.00
DME.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 667396.00
DME.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -1764453.00
DME.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 48783.00
DME.AX income_statement (annual, 2024-06-30) — Pretax Income: -2176776.00
DME.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -1290.00
DME.AX balance_sheet (annual, 2024-06-30) — Receivables: 88720.00
DME.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 4388.00
DME.AX income_statement (annual, 2024-06-30) — Rent And Landing Fees: 99940.00
DME.AX cash_flow (annual, 2024-06-30) — Repayment Of Debt: -266088.00
DME.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -61383.00
DME.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -22407438.00
DME.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 535838.00
DME.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 635778.00
DME.AX balance_sheet (annual, 2024-06-30) — Share Issued: 367739086.00
DME.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 34920429.00
DME.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 34920429.00
DME.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
DME.AX income_statement (annual, 2024-06-30) — Tax Provision: 11809.00
DME.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.30
DME.AX cash_flow (annual, 2024-06-30) — Taxes Refund Paid Direct: -27527.00
DME.AX balance_sheet (annual, 2024-06-30) — Total Assets: 36780035.00
DME.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 35789823.00
DME.AX balance_sheet (annual, 2024-06-30) — Total Debt: 920692.00
DME.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 34920429.00
DME.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 1610759.00
DME.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 36626536.00
DME.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 875754.00
DME.AX balance_sheet (annual, 2024-06-30) — Working Capital: -581506.00
DME.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 389759314.00
DME.AX income_statement (annual, 2025-06-30) — Basic EPS: -0.01
DME.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 389759314.00
DME.AX income_statement (annual, 2025-06-30) — Diluted EPS: -0.01
DME.V cash_flow (annual, 2021-09-30) — Amortization Cash Flow: 0.00
DME.V cash_flow (annual, 2021-09-30) — Amortization Of Intangibles: 0.00
DME.V cash_flow (annual, 2021-09-30) — Asset Impairment Charge: 602963.00
DME.V balance_sheet (annual, 2021-09-30) — Cash Equivalents: 9999993.00
DME.V balance_sheet (annual, 2021-09-30) — Cash Financial: 16614320.00
DME.V balance_sheet (annual, 2021-09-30) — Goodwill And Other Intangible Assets: 11600.00
DME.V income_statement (annual, 2021-09-30) — Impairment Of Capital Assets: 602963.00
DME.V balance_sheet (annual, 2021-09-30) — Machinery Furniture Equipment: 161352.00
DME.V cash_flow (annual, 2021-09-30) — Net PPE Purchase And Sale: -464857.00
DME.V balance_sheet (annual, 2021-09-30) — Other Short Term Investments: 204750.00
DME.V cash_flow (annual, 2021-09-30) — Proceeds From Stock Option Exercised: 18313808.00
DME.V cash_flow (annual, 2021-09-30) — Purchase Of PPE: -464857.00
DME.V income_statement (annual, 2021-09-30) — Tax Provision: 0.00
DME.V cash_flow (annual, 2021-09-30) — Unrealized Gain Loss On Investment Securities: 315000.00
DME.V income_statement (annual, 2022-09-30) — +Operating Expense: 6967795.00
DME.V income_statement (annual, 2022-09-30) — +Total Revenue: 443916.00
DME.V balance_sheet (annual, 2022-09-30) — Accounts Payable: 2324546.00
DME.V balance_sheet (annual, 2022-09-30) — Accounts Receivable: 412451.00
DME.V balance_sheet (annual, 2022-09-30) — Accumulated Depreciation: -155229.00
DME.V cash_flow (annual, 2022-09-30) — Amortization Cash Flow: 11600.00
DME.V cash_flow (annual, 2022-09-30) — Amortization Of Intangibles: 11600.00
DME.V cash_flow (annual, 2022-09-30) — Asset Impairment Charge: 0.00
DME.V income_statement (annual, 2022-09-30) — Basic Average Shares: 73722688.00
DME.V income_statement (annual, 2022-09-30) — Basic EPS: -0.10
DME.V cash_flow (annual, 2022-09-30) — Beginning Cash Position: 26614313.00
DME.V cash_flow (annual, 2022-09-30) — Capital Expenditure: -10090967.00
DME.V cash_flow (annual, 2022-09-30) — Capital Expenditure Reported: -10090967.00
DME.V balance_sheet (annual, 2022-09-30) — Capital Stock: 61606400.00
DME.V balance_sheet (annual, 2022-09-30) — Cash And Cash Equivalents: 12229781.00
DME.V balance_sheet (annual, 2022-09-30) — Cash Cash Equivalents And Short Term Investments: 12521156.00
DME.V cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Financing Activities: 6995854.00
DME.V cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Investing Activities: -17858425.00
DME.V cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Operating Activities: -3521961.00
DME.V cash_flow (annual, 2022-09-30) — Change In Account Payable: 140575.00
DME.V cash_flow (annual, 2022-09-30) — Change In Payable: 149404.00
DME.V cash_flow (annual, 2022-09-30) — Change In Payables And Accrued Expense: 149404.00
DME.V cash_flow (annual, 2022-09-30) — Change In Prepaid Assets: -127502.00
DME.V cash_flow (annual, 2022-09-30) — Change In Receivables: -393564.00
DME.V cash_flow (annual, 2022-09-30) — Change In Working Capital: -371662.00
DME.V cash_flow (annual, 2022-09-30) — Changes In Cash: -14384532.00
DME.V balance_sheet (annual, 2022-09-30) — Common Stock: 61606400.00
DME.V balance_sheet (annual, 2022-09-30) — Common Stock Equity: 37318270.00
DME.V cash_flow (annual, 2022-09-30) — Common Stock Issuance: 5420406.00
DME.V income_statement (annual, 2022-09-30) — Cost Of Revenue: 199500.00
DME.V balance_sheet (annual, 2022-09-30) — Current Assets: 13362516.00
DME.V balance_sheet (annual, 2022-09-30) — Current Liabilities: 2347955.00
DME.V cash_flow (annual, 2022-09-30) — Depletion: 0.00
DME.V income_statement (annual, 2022-09-30) — Depletion Income Statement: 0.00
DME.V cash_flow (annual, 2022-09-30) — Depreciation: 151767.00
DME.V cash_flow (annual, 2022-09-30) — Depreciation Amortization Depletion: 163367.00
DME.V income_statement (annual, 2022-09-30) — Depreciation Amortization Depletion Income Statement: 151767.00
DME.V cash_flow (annual, 2022-09-30) — Depreciation And Amortization: 163367.00
DME.V income_statement (annual, 2022-09-30) — Depreciation And Amortization In Income Statement: 151767.00
DME.V income_statement (annual, 2022-09-30) — Depreciation Income Statement: 151767.00
DME.V income_statement (annual, 2022-09-30) — Diluted Average Shares: 73722688.00
DME.V income_statement (annual, 2022-09-30) — Diluted EPS: -0.10
DME.V income_statement (annual, 2022-09-30) — Diluted NI Availto Com Stockholders: -7528076.00
DME.V balance_sheet (annual, 2022-09-30) — Dueto Related Parties Current: 23409.00
DME.V income_statement (annual, 2022-09-30) — EBIT: -6723379.00
DME.V income_statement (annual, 2022-09-30) — EBITDA: -6560012.00
DME.V cash_flow (annual, 2022-09-30) — Effect Of Exchange Rate Changes: 0.00
DME.V cash_flow (annual, 2022-09-30) — End Cash Position: 12229781.00
DME.V cash_flow (annual, 2022-09-30) — Financing Cash Flow: 6995854.00
DME.V cash_flow (annual, 2022-09-30) — Free Cash Flow: -13612928.00
DME.V income_statement (annual, 2022-09-30) — Gain On Sale Of Security: -941120.00
DME.V balance_sheet (annual, 2022-09-30) — Gains Losses Not Affecting Retained Earnings: 0.00
DME.V income_statement (annual, 2022-09-30) — General And Administrative Expense: 5251050.00
DME.V balance_sheet (annual, 2022-09-30) — Goodwill And Other Intangible Assets: 0.00
DME.V balance_sheet (annual, 2022-09-30) — Gross PPE: 25642201.00
DME.V income_statement (annual, 2022-09-30) — Gross Profit: 244416.00
DME.V balance_sheet (annual, 2022-09-30) — Held To Maturity Securities: 68693.00
DME.V income_statement (annual, 2022-09-30) — Impairment Of Capital Assets: 0.00
DME.V income_statement (annual, 2022-09-30) — Insurance And Claims: 720286.00
DME.V income_statement (annual, 2022-09-30) — Interest Income: 136423.00
DME.V income_statement (annual, 2022-09-30) — Interest Income Non Operating: 136423.00
DME.V balance_sheet (annual, 2022-09-30) — Invested Capital: 37318270.00
DME.V cash_flow (annual, 2022-09-30) — Investing Cash Flow: -17858425.00
DME.V balance_sheet (annual, 2022-09-30) — Investmentin Financial Assets: 68693.00
DME.V balance_sheet (annual, 2022-09-30) — Investments And Advances: 68693.00
DME.V cash_flow (annual, 2022-09-30) — Issuance Of Capital Stock: 5420406.00
DME.V balance_sheet (annual, 2022-09-30) — Land And Improvements: 120013.00
DME.V balance_sheet (annual, 2022-09-30) — Long Term Provisions: 352320.00
DME.V balance_sheet (annual, 2022-09-30) — Machinery Furniture Equipment: 9240611.00
DME.V cash_flow (annual, 2022-09-30) — Net Business Purchase And Sale: 0.00
DME.V cash_flow (annual, 2022-09-30) — Net Common Stock Issuance: 5420406.00
DME.V cash_flow (annual, 2022-09-30) — Net Foreign Currency Exchange Gain Loss: -49149.00
DME.V income_statement (annual, 2022-09-30) — Net Income: -7528076.00
DME.V income_statement (annual, 2022-09-30) — Net Income Common Stockholders: -7528076.00
DME.V income_statement (annual, 2022-09-30) — Net Income Continuous Operations: -7528076.00
DME.V income_statement (annual, 2022-09-30) — Net Income From Continuing And Discontinued Operation: -7528076.00
DME.V income_statement (annual, 2022-09-30) — Net Income From Continuing Operation Net Minority Interest: -7528076.00
DME.V cash_flow (annual, 2022-09-30) — Net Income From Continuing Operations: -7528076.00
DME.V income_statement (annual, 2022-09-30) — Net Income Including Noncontrolling Interests: -7528076.00
DME.V income_statement (annual, 2022-09-30) — Net Interest Income: 136423.00
DME.V cash_flow (annual, 2022-09-30) — Net Investment Purchase And Sale: 0.00
DME.V income_statement (annual, 2022-09-30) — Net Non Operating Interest Income Expense: 136423.00
DME.V cash_flow (annual, 2022-09-30) — Net Other Investing Changes: -7767458.00
DME.V balance_sheet (annual, 2022-09-30) — Net PPE: 25486972.00
DME.V cash_flow (annual, 2022-09-30) — Net PPE Purchase And Sale: 0.00
DME.V balance_sheet (annual, 2022-09-30) — Net Tangible Assets: 37318270.00
DME.V balance_sheet (annual, 2022-09-30) — Non Current Note Receivables: 1100364.00
DME.V income_statement (annual, 2022-09-30) — Normalized EBITDA: -5618892.00
DME.V income_statement (annual, 2022-09-30) — Normalized Income: -6586956.00
DME.V cash_flow (annual, 2022-09-30) — Operating Cash Flow: -3521961.00
DME.V cash_flow (annual, 2022-09-30) — Operating Gains Losses: -49149.00
DME.V income_statement (annual, 2022-09-30) — Operating Income: -6723379.00
DME.V income_statement (annual, 2022-09-30) — Operating Revenue: 443916.00
DME.V balance_sheet (annual, 2022-09-30) — Ordinary Shares Number: 77584895.00
DME.V balance_sheet (annual, 2022-09-30) — Other Equity Interest: 12181470.00
DME.V income_statement (annual, 2022-09-30) — Other Gand A: 863413.00
DME.V income_statement (annual, 2022-09-30) — Other Income Expense: -941120.00
DME.V cash_flow (annual, 2022-09-30) — Other Non Cash Items: 898337.00
DME.V balance_sheet (annual, 2022-09-30) — Other Non Current Liabilities: 6000.00
DME.V income_statement (annual, 2022-09-30) — Other Operating Expenses: 587390.00
DME.V balance_sheet (annual, 2022-09-30) — Other Properties: 25522188.00
DME.V balance_sheet (annual, 2022-09-30) — Other Short Term Investments: 291375.00
DME.V balance_sheet (annual, 2022-09-30) — Payables: 2347955.00
DME.V balance_sheet (annual, 2022-09-30) — Payables And Accrued Expenses: 2347955.00
DME.V balance_sheet (annual, 2022-09-30) — Prepaid Assets: 428909.00
DME.V income_statement (annual, 2022-09-30) — Pretax Income: -7528076.00
DME.V cash_flow (annual, 2022-09-30) — Proceeds From Stock Option Exercised: 1575448.00
DME.V cash_flow (annual, 2022-09-30) — Provisionand Write Offof Assets: 0.00
DME.V cash_flow (annual, 2022-09-30) — Purchase Of Business: 0.00
DME.V cash_flow (annual, 2022-09-30) — Purchase Of Investment: 0.00
DME.V cash_flow (annual, 2022-09-30) — Purchase Of PPE: -10090967.00
DME.V balance_sheet (annual, 2022-09-30) — Receivables: 412451.00
DME.V income_statement (annual, 2022-09-30) — Reconciled Cost Of Revenue: 187900.00
DME.V income_statement (annual, 2022-09-30) — Reconciled Depreciation: 163367.00
DME.V balance_sheet (annual, 2022-09-30) — Retained Earnings: -36469600.00
DME.V income_statement (annual, 2022-09-30) — Salaries And Wages: 3667351.00
DME.V cash_flow (annual, 2022-09-30) — Sale Of Investment: 0.00
DME.V cash_flow (annual, 2022-09-30) — Sale Of PPE: 0.00
DME.V income_statement (annual, 2022-09-30) — Securities Amortization: 0.00
DME.V income_statement (annual, 2022-09-30) — Selling And Marketing Expense: 782236.00
DME.V income_statement (annual, 2022-09-30) — Selling General And Administration: 6033286.00
DME.V balance_sheet (annual, 2022-09-30) — Share Issued: 77584895.00
DME.V income_statement (annual, 2022-09-30) — Special Income Charges: 0.00
DME.V cash_flow (annual, 2022-09-30) — Stock Based Compensation: 3451847.00
DME.V balance_sheet (annual, 2022-09-30) — Stockholders Equity: 37318270.00
DME.V balance_sheet (annual, 2022-09-30) — Tangible Book Value: 37318270.00
DME.V income_statement (annual, 2022-09-30) — Tax Effect Of Unusual Items: 0.00
DME.V income_statement (annual, 2022-09-30) — Tax Rate For Calcs: 0.00
DME.V balance_sheet (annual, 2022-09-30) — Total Assets: 40018545.00
DME.V balance_sheet (annual, 2022-09-30) — Total Capitalization: 37318270.00
DME.V balance_sheet (annual, 2022-09-30) — Total Equity Gross Minority Interest: 37318270.00
DME.V income_statement (annual, 2022-09-30) — Total Expenses: 7167295.00
DME.V balance_sheet (annual, 2022-09-30) — Total Liabilities Net Minority Interest: 2700275.00
DME.V balance_sheet (annual, 2022-09-30) — Total Non Current Assets: 26656029.00
DME.V balance_sheet (annual, 2022-09-30) — Total Non Current Liabilities Net Minority Interest: 352320.00
DME.V income_statement (annual, 2022-09-30) — Total Unusual Items: -941120.00
DME.V income_statement (annual, 2022-09-30) — Total Unusual Items Excluding Goodwill: -941120.00
DME.V cash_flow (annual, 2022-09-30) — Unrealized Gain Loss On Investment Securities: -86625.00
DME.V balance_sheet (annual, 2022-09-30) — Working Capital: 11014561.00
DME.V income_statement (annual, 2022-09-30) — Write Off: 0.00
DME.V income_statement (annual, 2023-09-30) — +Operating Expense: 7596318.00
DME.V income_statement (annual, 2023-09-30) — +Total Revenue: 1743622.00
DME.V balance_sheet (annual, 2023-09-30) — Accounts Payable: 918543.00
DME.V balance_sheet (annual, 2023-09-30) — Accounts Receivable: 843405.00
DME.V balance_sheet (annual, 2023-09-30) — Accumulated Depreciation: -5846505.00
DME.V cash_flow (annual, 2023-09-30) — Amortization Cash Flow: 0.00
DME.V cash_flow (annual, 2023-09-30) — Amortization Of Intangibles: 0.00
DME.V cash_flow (annual, 2023-09-30) — Asset Impairment Charge: 5269061.00
DME.V income_statement (annual, 2023-09-30) — Basic Average Shares: 84265706.00
DME.V income_statement (annual, 2023-09-30) — Basic EPS: -0.14
DME.V cash_flow (annual, 2023-09-30) — Beginning Cash Position: 12229781.00
DME.V cash_flow (annual, 2023-09-30) — Capital Expenditure: -9438156.00
DME.V cash_flow (annual, 2023-09-30) — Capital Expenditure Reported: -9438156.00
DME.V balance_sheet (annual, 2023-09-30) — Capital Stock: 80775376.00
DME.V balance_sheet (annual, 2023-09-30) — Cash And Cash Equivalents: 12091882.00
DME.V balance_sheet (annual, 2023-09-30) — Cash Cash Equivalents And Short Term Investments: 12091882.00
DME.V cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Financing Activities: 21430657.00
DME.V cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Investing Activities: -16879203.00
DME.V cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Operating Activities: -4699679.00
DME.V cash_flow (annual, 2023-09-30) — Change In Account Payable: 175653.00
DME.V cash_flow (annual, 2023-09-30) — Change In Payable: 190042.00
DME.V cash_flow (annual, 2023-09-30) — Change In Payables And Accrued Expense: 190042.00
DME.V cash_flow (annual, 2023-09-30) — Change In Prepaid Assets: -192560.00
DME.V cash_flow (annual, 2023-09-30) — Change In Receivables: -588166.00
DME.V cash_flow (annual, 2023-09-30) — Change In Working Capital: -590684.00
DME.V cash_flow (annual, 2023-09-30) — Changes In Cash: -148225.00
DME.V balance_sheet (annual, 2023-09-30) — Common Stock: 80775376.00
DME.V balance_sheet (annual, 2023-09-30) — Common Stock Equity: 50768595.00
DME.V cash_flow (annual, 2023-09-30) — Common Stock Issuance: 21149737.00
DME.V income_statement (annual, 2023-09-30) — Cost Of Revenue: 879116.00
DME.V balance_sheet (annual, 2023-09-30) — Current Assets: 13570688.00
DME.V balance_sheet (annual, 2023-09-30) — Current Liabilities: 956341.00
DME.V cash_flow (annual, 2023-09-30) — Depletion: 68957.00
DME.V income_statement (annual, 2023-09-30) — Depletion Income Statement: 68957.00
DME.V cash_flow (annual, 2023-09-30) — Depreciation: 342682.00
DME.V cash_flow (annual, 2023-09-30) — Depreciation Amortization Depletion: 411639.00
DME.V income_statement (annual, 2023-09-30) — Depreciation Amortization Depletion Income Statement: 411639.00
DME.V cash_flow (annual, 2023-09-30) — Depreciation And Amortization: 342682.00
DME.V income_statement (annual, 2023-09-30) — Depreciation And Amortization In Income Statement: 342682.00
DME.V income_statement (annual, 2023-09-30) — Depreciation Income Statement: 342682.00
DME.V income_statement (annual, 2023-09-30) — Diluted Average Shares: 84265706.00
DME.V income_statement (annual, 2023-09-30) — Diluted EPS: -0.14
DME.V income_statement (annual, 2023-09-30) — Diluted NI Availto Com Stockholders: -11591723.00
DME.V balance_sheet (annual, 2023-09-30) — Dueto Related Parties Current: 37798.00
DME.V income_statement (annual, 2023-09-30) — EBIT: -6731812.00
DME.V income_statement (annual, 2023-09-30) — EBITDA: -6320173.00
DME.V cash_flow (annual, 2023-09-30) — Effect Of Exchange Rate Changes: 10326.00
DME.V cash_flow (annual, 2023-09-30) — End Cash Position: 12091882.00
DME.V cash_flow (annual, 2023-09-30) — Financing Cash Flow: 21430657.00
DME.V cash_flow (annual, 2023-09-30) — Free Cash Flow: -14137835.00
DME.V cash_flow (annual, 2023-09-30) — Gain Loss On Sale Of PPE: 0.00
DME.V income_statement (annual, 2023-09-30) — Gain On Sale Of Ppe: 0.00
DME.V income_statement (annual, 2023-09-30) — Gain On Sale Of Security: -226161.00
DME.V balance_sheet (annual, 2023-09-30) — Gains Losses Not Affecting Retained Earnings: 1722702.00
DME.V income_statement (annual, 2023-09-30) — General And Administrative Expense: 4839694.00
DME.V balance_sheet (annual, 2023-09-30) — Gross PPE: 50956108.00
DME.V income_statement (annual, 2023-09-30) — Gross Profit: 864506.00
DME.V balance_sheet (annual, 2023-09-30) — Held To Maturity Securities: 101837.00
DME.V income_statement (annual, 2023-09-30) — Impairment Of Capital Assets: 5269061.00
DME.V income_statement (annual, 2023-09-30) — Insurance And Claims: 718099.00
DME.V income_statement (annual, 2023-09-30) — Interest Income: 792523.00
DME.V income_statement (annual, 2023-09-30) — Interest Income Non Operating: 792523.00
DME.V balance_sheet (annual, 2023-09-30) — Invested Capital: 50768595.00
DME.V cash_flow (annual, 2023-09-30) — Investing Cash Flow: -16879203.00
DME.V balance_sheet (annual, 2023-09-30) — Investmentin Financial Assets: 101837.00
DME.V balance_sheet (annual, 2023-09-30) — Investments And Advances: 101837.00
DME.V cash_flow (annual, 2023-09-30) — Issuance Of Capital Stock: 21149737.00
DME.V balance_sheet (annual, 2023-09-30) — Land And Improvements: 271726.00
DME.V balance_sheet (annual, 2023-09-30) — Long Term Provisions: 7722488.00
DME.V balance_sheet (annual, 2023-09-30) — Machinery Furniture Equipment: 18356573.00
DME.V cash_flow (annual, 2023-09-30) — Net Business Purchase And Sale: -3310000.00
DME.V cash_flow (annual, 2023-09-30) — Net Common Stock Issuance: 21149737.00
DME.V cash_flow (annual, 2023-09-30) — Net Foreign Currency Exchange Gain Loss: 305922.00
DME.V income_statement (annual, 2023-09-30) — Net Income: -11591723.00
DME.V income_statement (annual, 2023-09-30) — Net Income Common Stockholders: -11591723.00
DME.V income_statement (annual, 2023-09-30) — Net Income Continuous Operations: -11591723.00
DME.V income_statement (annual, 2023-09-30) — Net Income From Continuing And Discontinued Operation: -11591723.00
DME.V income_statement (annual, 2023-09-30) — Net Income From Continuing Operation Net Minority Interest: -11591723.00
DME.V cash_flow (annual, 2023-09-30) — Net Income From Continuing Operations: -11591723.00
DME.V income_statement (annual, 2023-09-30) — Net Income Including Noncontrolling Interests: -11591723.00
DME.V income_statement (annual, 2023-09-30) — Net Interest Income: 792523.00
DME.V cash_flow (annual, 2023-09-30) — Net Investment Purchase And Sale: 285890.00
DME.V income_statement (annual, 2023-09-30) — Net Non Operating Interest Income Expense: 792523.00
DME.V cash_flow (annual, 2023-09-30) — Net Other Investing Changes: -4425029.00
DME.V balance_sheet (annual, 2023-09-30) — Net PPE: 45109603.00
DME.V cash_flow (annual, 2023-09-30) — Net PPE Purchase And Sale: 8092.00
DME.V balance_sheet (annual, 2023-09-30) — Net Tangible Assets: 50768595.00
DME.V balance_sheet (annual, 2023-09-30) — Non Current Note Receivables: 665296.00
DME.V income_statement (annual, 2023-09-30) — Normalized EBITDA: -667739.00
DME.V income_statement (annual, 2023-09-30) — Normalized Income: -5939289.00
DME.V cash_flow (annual, 2023-09-30) — Operating Cash Flow: -4699679.00
DME.V cash_flow (annual, 2023-09-30) — Operating Gains Losses: 305922.00